4.86
0.05 (1.04%)
| Penutupan Terdahulu | 4.81 |
| Jumlah Dagangan | 139,272 |
| Harga / Pendapatan (P/E Ke hadapan) | 19.53 |
| Harga / Jualan (P/S) | 2.02 |
| Harga / Buku (P/B) | 3.25 |
| Julat 52 Minggu |
| Margin Keuntungan | 11.40% |
| Margin Operasi (TTM) | 9.35% |
| EPS Cair (TTM) | 0.270 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 4.10% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -24.20% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 9.20% |
| Nisbah Semasa (MRQ) | 4.70 |
| Aliran Tunai Operasi (OCF TTM) | 65.52 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 53.10 M |
| Pulangan Atas Aset (ROA TTM) | 13.80% |
| Pulangan Atas Ekuiti (ROE TTM) | 22.29% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | MiMedx Group, Inc | Bercampur | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -1.0 |
| Purata Bergerak Teknikal | 5.0 |
| Osilator Teknikal | 2.0 |
| Purata | 1.50 |
|
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 1.71% |
| % Dimiliki oleh Institusi | 70.12% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Essex Woodlands Management, Inc. | 30 Jun 2026 | 28,195,249 |
| Trigran Investments, Inc. | 30 Jun 2026 | 7,173,770 |
| Paradigm Capital Management Inc/Ny | 30 Jun 2026 | 4,073,100 |
| Cannell Capital Llc | 30 Jun 2026 | 1,870,436 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |